SC12267 (4SC-101): Clinical Trials

2 trials of SC12267 (4SC-101), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2

Follow SC12267 (4SC-101): new trials by email Literature Review of SC12267 (4SC-101) trials Research Report on SC12267 (4SC-101)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
SC12267 (4SC-101) in Combination With Methotrexate in Patients With Rheumatoid Arthritis
SC12267 (4SC-101), Placebo, Methotrexate - Rheumatoid Arthritis
Phase 2Completed4SC AG2662009-11-012012-03-01
SC12267 (4SC-101) for Treatment of Patients With Inflammatory Bowel Disease
SC12267 (4SC-101) - Inflammatory Bowel Disease (IBD)
Phase 2Completed4SC AG342009-03-012011-05-18

Conditions studied

Arthritis, Rheumatoid (1)  ·  Colitis, Ulcerative (1)  ·  Crohn Disease (1)  ·  Inflammatory Bowel Diseases (1)

Sponsors

4SC AG (2)

Countries

Bulgaria (2)  ·  Romania (2)  ·  Czechia (1)  ·  Germany (1)  ·  Poland (1)

Top investigators

Klaus Herrlinger, Prof. (1)

Results publications

PMID 20413687, PMID 23078909, PMID 31621054